RankAlpha logo
Back to Rankings

PBH

Prestige Consumer HealthcareA
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Diversified branded consumer-health products, Q1 execution above expectations, raised fiscal 2027 guidance, acquisition contributions, and record adjusted free cash flow support a cautiously positive outlook.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +9.7.
What can break
Approximately $2 billion of net debt increases sensitivity to integration execution, cash-flow conversion, and deleveraging progress. [#SEC-8K-2026-08-06]
Momentum
28
Value
67
Sentiment
84
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $55.20 · Bull $67.25 · Bear $47.38Analysis 2026-09-02; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-02 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-09

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions

Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $67.25
Why
Momentum28 · Δ7d +17.4
Value67 · Δ7d 0.0
Sentiment84 · Δ7d +9.7
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Sentiment remains the lead driver in the composite, 7D delta +9.7.

Contradictions & invalidation

  • • Approximately $2 billion of net debt increases sensitivity to integration execution, cash-flow conversion, and deleveraging progress. [#SEC-8K-2026-08-06]
  • • Clear Eyes performance and supply availability were below expectations or variable. [#SEC-8K-2026-08-06]
  • • Approximately $2 billion of net debt, acquisition-integration demands, Clear Eyes variability, supply-chain uncertainty, and the operations leadership transition could limit earnings durability or compress valuation.

Catalyst clock

2026-08-06

Q1 FY2027 beat and raised outlook

Lead driver: Sentiment · See AI snapshot
Momentum
28
9% active weight
Current posture
7d trendImproving
Δ7d
+17.4
Δ21d
+14.0
Value
67
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-2.0
Sentiment
84
62% active weight
Current posture
7d trendImproving
Δ7d
+9.7
Δ21d
+2.5
Why this grade

Composite grade A. Momentum 27.5 / Value 67.3 / Sentiment 83.7

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-02. Scenario method

B+
Bull case
25%
Probability
Target price
$67.25
Analysis reference price unavailable
Analysis 2026-09-02 · RankAlpha Sentiment Codex
Most likely
B
Base case
55%
Probability
Target price
$55.20
Analysis reference price unavailable
Analysis 2026-09-02 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$47.38
Analysis reference price unavailable
Analysis 2026-09-02 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$2.37B
Beta
0.43
Shares Out
47.37M
P/E (TTM)
15.5
P/S (TTM)
2.71
P/FCF (TTM)
11.76
Rev YoY
+6.5%
EPS YoY
-35.7%
Gross Margin
+51.6%
Op Margin
+26.3%
Net Debt
$981.56M
Current Ratio
3.23
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data